New Marker Identified on Tumors Improves Immunotherapy – New Study
Tumors are heterogenous masses of cells that rapidly divide. Many cells have different mutations, functions, and ways to avoid immune cell detection and dr
Summary
Tumors are complex and heterogenous masses of cells characterized by rapid, uncontrolled division. This cellular diversity includes various mutations affecting cell function and the ability to evade the immune system. This heterogeneity is a major challenge in cancer treatment, as different subpopulations of tumor cells may respond differently to therapies, leading to resistance and disease progression. Understanding this complexity is crucial for developing effective and targeted cancer treatments.
Read more…
Credits: Source
This post is part of “Science/Immunology News”, Follow for more…!!!